Long Term Open Label Continuation Study
Study Identifier
DE020
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
18+ years
Protocol Summary
The purpose of the study was to assess the long-term safety and clinical efficacy following
repeated administration of adalimumab in patients with rheumatoid arthritis.
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 538
Birmingham, Alabama, United States, 35205
Status
Not applicable
Location
Site Reference ID/Investigator# 4111
Birmingham, Alabama, United States, 35294-7201
Status
Not applicable
Location
Site Reference ID/Investigator# 4113
Mobile, Alabama, United States, 36608
Status
Not applicable
Location
Site Reference ID/Investigator# 408
Anchorage, Alaska, United States, 99508
Status
Not applicable
Location
Site Reference ID/Investigator# 537
Tucson, Arizona, United States, 85710
Status
Not applicable
Location
Site Reference ID/Investigator# 66822
Anaheim, California, United States, 92801
Status
Not applicable
Showing {first} - {last} of {total} Results